Showing results (1251-1260 of 1,488) with videos related to

Sort By:
Pageof 149
Pharmacology, Biochemistry, and Behavior|December 24, 2024
Emerging medications and pharmacological treatment approaches for substance use disordersJoel S Raymond, Alexander G Athanasopoulos, Connie J Badolato, et al.
SAR and QSAR in Environmental Research|July 10, 2023
Design and experimental validation of the oxazole and thiazole derivatives as potential antivirals against of human cytomegalovirusV Kovalishyn, O Severin, M Kachaeva, et al.
PLOS Mental Health|September 2, 2025
Perspectives and experiences with sleep and recovery among women receiving buprenorphine for opioid use disorderMichelle Eglovitch, Anna Beth Parlier-Ahmad, Alison J Patev, et al.
Journal of the American Dental Association (1939)|February 7, 2006
Odontogenic signs and symptoms as predictors of odontogenic infection: a clinical trialMichael T Brennan, Michael S Runyon, Jayne J Batts, et al.
Molecular Biotechnology|January 29, 2023
In Silico Design and Experimental Validation of Novel Oxazole Derivatives Against Varicella zoster virusVasyl Kovalishyn, Oleksandr Severin, Maryna Kachaeva, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 29, 2014
mTORC1 inhibition in the nucleus accumbens 'protects' against the expression of drug seeking and 'relapse' and is associated with reductions in GluA1 AMPAR and CAMKIIα levelsMorgan H James, Rikki K Quinn, Lin Kooi Ong, et al.
Injury|July 15, 2009
Removal of erythropoietin from anaemia trauma practice guideline does not increase red blood cell transfusions and decreases hospital utilization costsA Britton Christmas, Steven M Camp, M Craig Barrett, et al.
The Spine Journal : Official Journal of the North American Spine Society|March 20, 2012
Deleterious effects of discography radiocontrast solution on human annulus cell in vitro: changes in cell viability, proliferation, and apoptosis in exposed cellsHelen E Gruber, Alfred L Rhyne, Kristopher J Hansen, et al.
Immunotherapy|October 18, 2019
Immune globulin subcutaneous, human - klhw 20% for primary humoral immunodeficiency: an open-label, Phase III studyJohn W Sleasman, William R Lumry, Iftikhar Hussain, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 22, 2000
Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopinP R Holden, S C Hasmall, N H James, et al.
Pageof 149